Domestic Presence

Domestic Presence

One of the largest manufacturer in its segment in the Indian Pharmaceutical Market, Axa is one of the fastest growing Indian pharmaceutical conglomerate. Driven by a sustainable business model, Axa has been consistently outperforming the market with more than 35% growth. Its 4 Strategic Business Units employ a multidivisional model, catering to various therapy areas for enhanced focus towards brand and market development. On the foundation of this diversified revenue base, Axa has gained an influential presence in India with an expanding market share and improving ranks across years.

The current emphasis is on Intravenous Fluids Therapy, Respiratory Segment Products, Ophthalmology including Preservative Free Single Dose Delivery System and Preservative Free Multi-dose Delivery Systems which is unique and the only one in India, along with General Injectables, Cephalosporins, Carbapenems, Anti-cancer Products including MABs (Monoclonal Antibodies). While Axa enjoys leadership status in the Intra-venous Fluids segment, with the launch of Steridrip and BioAxa, and appointment of 500 plus channel partners, we have significantly increased our market penetration.

APL Unit-II is the talk of the town due to its diverse manufacturing capabilities and the Pharmaceutical segments caters to and also due to its tallest infrastructure. It has been built especially to cater to the Highly Regulated Markets of the Globe line Europe, Australia, United Kingdom and US Pharmaceutical markets.

AXACARE

"Saving Life Beyond Excellence"

BIOAXA

"Caring for life"

LUMERA

"The Power of Vision"